Functional relevance of nonsynonymous mutations in the HIV-1 tat gene within an epidemiologically-linked transmission cohort

Virology Journal

Volumn 4, Issue , 2007, Pages

  Sivakumaran, Haran ^a,b   Wang, Bin ^c   Gill, M John ^d   Beckholdt, Brenda ^d   Saksena, Nitin K ^c   Harrich, David ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; GENE MUTATION; GENETIC VARIABILITY; HOST RANGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE SYSTEM; PHYLOGENY; TRANSACTIVATION; VIRUS TRANSMISSION; BLOOD TRANSFUSION; CHEMISTRY; CLASSIFICATION; DISEASE TRANSMISSION; EXON; GENETICS; HELA CELL; IMMUNOLOGY; MUTATION; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

TRANSACTIVATOR PROTEIN;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BLOOD TRANSFUSION; COHORT STUDIES; EXONS; GENE PRODUCTS, TAT; HELA CELLS; HIV-1; HUMANS; MUTATION;

EID: 37849024112     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-4-107     Document Type: Article

References (19)

1. Role of viral evolutionary rate in HIV-1 disease progression in a linked cohort. M Mikhail B Wang B Lemey B Beckthold A Vandamme JM Gill NK Saksena, Retrovirology 2005 2 1 41 15985187 10.1186/1742-4690-2-41
2. Significance of plasma and peripheral blood mononuclear cell derived HIV-1 sequences in establishing epidemiologic linkage between two individuals multiply exposed to HIV-1. JZ Song B Wang YC Ge DE Dwyer AL Cunningham NK Saksena, Microb Pathog 1999 26 6 287 298 10.1006/mpat.1999.0275 10343057
3. Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). SK Arya C Guo SF Josephs F Wong-Staal, Science 1985 229 4708 69 73 10.1126/science.2990040 2990040
4. Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III. J Sodroski R Patarca C Rosen F Wong-Staal W Haseltine, Science 1985 229 4708 74 77 10.1126/science.2990041 2990041
5. Multiple effects of HIV-1 trans-activator protein on the pathogenesis of HIV-1 infection. MC Huigen W Kamp HS Nottet, Eur J Clin Invest 2004 34 1 57 66 10.1111/j.1365-2362.2004.01282.x 14984439
6. Mechanistic aspects of HIV-1 reverse transcription initiation. D Harrich B Hooker, Rev Med Virol 2002 12 1 31 45 10.1002/rmv.339 11787082
7. A review of HIV-1 Tat protein biological effects. A Pugliese V Vidotto T Beltramo S Petrini D Torre, Cell Biochem Funct 2005 23 4 223 227 10.1002/cbf.1147 15473004
8. Absence of selection of HIV-1 variants in vivo based on transcription/transactivation during progression to AIDS. S Delassus A Meyerhans R Cheynier S Wain-Hobson, Virology 1992 188 2 811 818 10.1016/0042-6822(92) 90536-X 1350126
9. Full-length HIV type 1 genome analysis showing evidence for HIV type 1 transmission from a nonprogressor to two recipients who progressed to AIDS. M Mikhail B Wang P Lemey B Beckholdt AM Vandamme MJ Gill NK Saksena, AIDS Res Hum Retroviruses 2005 21 6 575 579 10.1089/aid.2005.21.575 15989463
10. HIV Sequence Compendium 2005. T Leitner B Foley B Hahn P Marx F McCutchan J Mellors S Wolinsky B Korber, New Mexico, USA, Theoretical Biology and Biophysics Group, Los Alamos National Laboratory 2005
11. HIV Sequence Database. http://www.hiv.lanl.gov/content/hiv-db/mainpage. html
12. Transactivation induced by human T-lymphotropic virus type III (HTLV III) maps to a viral sequence encoding 58 amino acids and lacks tissue specificity. LJ Seigel L Ratner SF Josephs D Derse MB Feinberg GR Reyes SJ O'Brien F Wong-Staal, Virology 1986 148 1 226 231 10.1016/0042-6822(86)90419-8 3002031
13. Structural analysis of wild-type and mutant human immunodeficiency virus type 1 Tat proteins. AP Rice F Carlotti, J Virol 1990 64 12 6018 6026 2243385
14. Intracellular analysis of in vitro modified HIV Tat protein. SE Koken AE Greijer K Verhoef J van Wamel AG Bukrinskaya B Berkhout, J Biol Chem 1994 269 11 8366 8375 8132560
15. A second-site mutation that restores replication of a Tat-defective human immunodeficiency virus. K Verhoef B Berkhout, J Virol 1999 73 4 2781 2789 10074125
16. Determination of the minimal amount of Tat activity required for human immunodeficiency virus type 1 replication. K Verhoef M Koper B Berkhout, Virology 1997 237 2 228 236 10.1006/viro.1997.8786 9356335
17. Human immunodeficiency virus type 1 reverse transcription is stimulated by tat from other lentiviruses. CW Hooker J Scott A Apolloni E Parry D Harrich, Virology 2002 300 2 226 235 10.1006/viro.2002.1554 12350353
18. Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein. J Hauber MH Malim BR Cullen, J Virol 1989 63 3 1181 1187 2536828
19. Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis. M Kuppuswamy T Subramanian A Srinivasan G Chinnadurai, Nucleic Acids Res 1989 17 9 3551 3561 2542902 10.1093/nar/17.9.3551